Get started
GLAXO SMITHKLINE PGLAXO SMITHKLINE PGLAXO SMITHKLINE P

GLAXO SMITHKLINE P

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

GLAXO chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪445.64 B‬INR
Dividend yield (indicated)
1.22%
Price to earnings Ratio (TTM)
74.50
Basic EPS (TTM)
34.85INR
Net income (FY)
‪5.90 B‬INR
Revenue (FY)
‪34.54 B‬INR
Shares float
‪41.39 M‬
Beta (1Y)
1.32

About GLAXO SMITHKLINE P

Sector
Health Technology
CEO
Bhushan Akshikar
Headquarters
Mumbai
Website
gsk-india.com
Founded
1924
ISIN
INE159A01016
FIGI
BBG000CRN7T4
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. Its prescription medicines range across therapeutic areas such as anti-infective, dermatology, gynecology, diabetes, cardiovascular disease and respiratory diseases. The vaccines products include prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenza, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia and others. The company was founded in 1924 and is headquartered in Mumbai, India.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GLAXO is 2619.30 INR — it has increased by 0.96% in the past 24 hours. Watch GLAXO SMITHKLINE P stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange GLAXO SMITHKLINE P stocks are traded under the ticker GLAXO.
GLAXO stock has risen by 6.48% compared to the previous week, the month change is a 23.60% rise, over the last year GLAXO SMITHKLINE P has showed a 100.66% increase.
We've gathered analysts' opinions on GLAXO SMITHKLINE P future price: according to them, GLAXO price has a max estimate of 3000.00 INR and a min estimate of 2270.00 INR. Watch GLAXO chart and read a more detailed GLAXO SMITHKLINE P stock forecast: see what analysts think of GLAXO SMITHKLINE P and suggest that you do with its stocks.
GLAXO reached its all-time high on May 24, 2024 with the price of 2534.00 INR, and its all-time low was 110.00 INR and was reached on Sep 27, 2001. View more price dynamics on GLAXO chart.
See other stocks reaching their highest and lowest prices.
GLAXO stock is 5.58% volatile and has beta coefficient of 1.32. Track GLAXO SMITHKLINE P stock price on the chart and check out the list of the most volatile stocks — is GLAXO SMITHKLINE P there?
Today GLAXO SMITHKLINE P has the market capitalization of ‪445.64 B‬, it has increased by 2.51% over the last week.
Yes, you can track GLAXO SMITHKLINE P financials in yearly and quarterly reports right on TradingView.
GLAXO SMITHKLINE P is going to release the next earnings report on Jul 22, 2024. Keep track of upcoming events with our Earnings Calendar.
GLAXO net income for the last quarter is ‪1.94 B‬ INR, while the quarter before that showed ‪457.20 M‬ INR of net income which accounts for 325.37% change. Track more GLAXO SMITHKLINE P financial stats to get the full picture.
Yes, GLAXO dividends are paid annually. The last dividend per share was 32.00 INR. As of today, Dividend Yield (TTM)% is 1.22%. Tracking GLAXO SMITHKLINE P dividends might help you take more informed decisions.
GLAXO SMITHKLINE P dividend yield was 1.65% in 2023, and payout ratio reached 91.87%. The year before the numbers were 2.42% and 88.77% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GLAXO SMITHKLINE P EBITDA is ‪9.09 B‬ INR, and current EBITDA margin is 26.31%. See more stats in GLAXO SMITHKLINE P financial statements.
Like other stocks, GLAXO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GLAXO SMITHKLINE P stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GLAXO SMITHKLINE P technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GLAXO SMITHKLINE P stock shows the strong buy signal. See more of GLAXO SMITHKLINE P technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.